[Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].

Abstract

The development of anti-factor VIII/IX antibodies (inhibitor-induction) and the transmission of viral infections are the most significant complications of haemophilia treatment. The Humafactor-8 and Humafactor-9 are high-purity pasteurized factor VIII and IX concentrates, which are produced from pooled plasma of Hungarian donors by ion-exchange… (More)

Topics

Cite this paper

@article{Nemes1998ClinicalEO, title={[Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].}, author={L. M. Nemes and Andrea Cegledi and G. Keszthelyi - Szab{\'o} and Marta E. Alonso de La Varga and Georgetta Sas}, journal={Orvosi hetilap}, year={1998}, volume={139 13}, pages={749-52} }